Doxecitin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Doxecitin, covering 2025-07-28 to 2025-07-28. Get the full timeline:
Most recent: Clinical Trial Update: Doxecitin and Doxribthymine in Adult Subjects With Thymidine Kinase 2 (TK2) Deficiency [Phase 2]